Synthesis and inhibitory activity of new benzimidazole derivatives against Burkitt’s lymphoma promotion

Add time:07/18/2019    Source:sciencedirect.com

As a continuation to our previous work concerning antitumor benzimidazoles, we have synthesized series of new derivatives of 2-(1-benzyl-2-methyl-1H-benzimidazol-5-ylimino)-3-(substituted)-thiazolidin-4-one (6a–e), 3-(2-methyl-1H-benzimidazol-5-yl)-2-substituted-thiazolidin-4-one (9a–f) and we have studied their inhibitory activity against the Epstein–Barr virus-early antigen (EBV-EA) activation introduced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Compound 6d was found to be significantly active and compounds 5a and 6e were also active.

We also recommend Trading Suppliers and Manufacturers of 2-(Pentafluoroethyl)benzimidazole (cas 383-08-4). Pls Click Website Link as below: cas 383-08-4 suppliers

Prev:Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of some benzimidazole derivatives with trichomonicidal activity
Next:The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis)